Decorin links low-density lipoproteins (LDL) to collagen: A novel mechanism for retention of LDL in the atherosclerotic plaque

Trends in Cardiovascular Medicine

Volumn 9, Issue 3-4, 1999, Pages 86-91

  Kovanen, Petri T ^a   Pentikäinen, Markku O ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DECORIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ARTERY INTIMA; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; EXTRACELLULAR MATRIX; HUMAN; LIPID STORAGE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION; REVIEW;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; ARTERIES; ARTERIOSCLEROSIS; BINDING SITES; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIPOPROTEINS, LDL; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA; TUNICA INTIMA;

EID: 0033117090     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00013-4     Document Type: Review

References (58)

1. Alavi M., Moore S. Glycosaminoglycan composition and biosynthesis in the endothelium-covered neointima of de-endothelialized rabbit aorta. Exp Mol Pathol. 42:1985;389-400.
2. Borén J., Olin K., Lee I., Chait A., Wight T.N., Innerarity T.L. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B. 100(severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 101):1998;2658-2664. a.
3. Borén J, Olin K, O'Brien KD et al.: 1998b. Engineering non-atherogenic low density lipoproteins-direct evidence for the "response-to-retention" hypothesis of atherosclerosis. (abst) Circulation 98:I-314.
4. Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue. its possible role in atherogenesis Adv Lipid Res. 19:1982;1-53.
5. Camejo G., Fager G., Rosengren B., Hurt-Camejo E., Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 268:1993;14,131-14,137.
6. Carew T.E., Pittman R.C., Marchand E.R., Steinberg D. Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta. predominance of intimal degradation Arteriosclerosis. 4:1984;214-224.
7. Curran R.C., Crane W.A. Mucopolysaccharides in the atheromatous aorta. J Pathol Bacteriol. 84:1962;405-412.
8. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 136:1997;729-743.
9. Guyton J.R., Bocan T.M., Schifani T.A. Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta. Arteriosclerosis. 5:1985;644-652.
10. Hakala J.K., Öörni K., Ala-Korpela M., Kovanen P.T. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. Arterioscler Thromb Vasc Biol. 19:1999;1276-1283.
11. Hanson A.N., Bentley J.P. Quantitation of type I to type III collagen ratios in small samples of human tendon, blood vessels, and atherosclerotic plaque. Anal Biochem. 130:1983;32-40.
12. Hoff H.F., Jackson R.L., Mao S.J.T., Gotto A.M. Jr. Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody. Biochim Biophys Acta. 351:1974;407-415.
13. Hoff H.F., Wagner W.D. Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition. Atherosclerosis. 61:1986;231-236.
14. Hollander W. Unified concept on the role of acid mucopolysaccharides and connective tissue proteins in the accumulation of lipids, lipoproteins and calcium on the atherosclerotic plaque. Exp Mol Pathol. 25:1976;106-120.
15. Hoover G.A., McCormick S., Kalant N. Interaction of native and cell-modified low density lipoprotein with collagen gel. Arteriosclerosis. 8:1988;525-534.
16. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Wiklund O., Bondjers G. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res. 31:1990;1387-1398.
17. Iozzo R.V. The family of the small leucine-rich proteoglycans. key regulators of matrix assembly and cellular growth Crit Rev Biochem Mol Biol. 32:1997;141-174.
18. Jimi S., Sakata N., Matunaga A., Takebayashi S. Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens. Atherosclerosis. 107:1994;109-116.
19. Krumdieck R., Höök M., Rosenberg L.C., Volanakis J.E. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol. 149:1992;3695-3701.
20. Krusius T., Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA. 83:1986;7683-7687.
21. Mar H., Wight T.N. Colloidal gold immunostaining of deplasticized ultrathin sections. J Histochem Cytochem. 36:1988;1387-1395.
22. Morton L.F., Barnes M.J. Collagen polymorphism in the normal and diseased blood vessel wall. investigation of collagen types I, III, and V Atherosclerosis. 42:1982;41-51.
23. Murata K., Motayama T., Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 60:1986;251-262.
24. Nievelstein-Post P., Mottino G., Fogelman A.M., Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb. 14:1994;1151-1161.
25. Öörni K., Hakala J.K., Annila A., Ala-Korpela M., Kovanen P.T. Sphingomyelinase induces aggregation and fusion, but phospholipase A(2) only aggregation, of low density lipoprotein (LDL) particles - Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem. 273:1992;29,127-129,134.
26. Öörni K., Pentikäinen M.O., Annila A., Kovanen P.T. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. dependence on oxidative oxidative modification of the lysine residues J Biol Chem. 272:1997;21,303-21,311.
27. Paananen K., Kovanen P.T. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J Biol Chem. 269:1994;2023-2031.
28. Paananen K., Saarinen J., Annila A., Kovanen P.T. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans. J Biol Chem. 270:1995;12,257-12,262.
29. Pasquinelli G., Preda P., Vici M.et al. Electron microscopy of lipid deposits in human atherosclerosis. Scanning Microsc. 3:1989;1151-1159.
30. Pentikäinen M.O., Öörni K., Lassila R., Kovanen P.T. The proteoglycan decorin links low density lipoproteins with collagen type I. J Biol Chem. 272:1997;7633-7638.
31. Pillarisetti S., Paka L., Obunike J.C., Gerglund L., Goldberg I.J. Subendothelial retention of lipoprotein(a). evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix J Clin Invest. 100:1997;867-874.
32. Reichl D., Postiglione A., Myant N.B., Pflug J.J., Milis G.L. The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin Sci Mol Med. 49:1973;419-426.
33. Riessen R., Isner J.M., Blessing E., Loushin C., Nikol S., Wight T.N. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 144:1994;962-974.
34. Romano M., Romano E., Björkerud S., Hurt-Camejo E. Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. Arterioscler Thromb Vasc Biol. 18:1998;519-525.
35. Rosenfeld M.E., Palinski W., Ylä-Herttuala S., Butler S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
36. Sambandam T., Baker J.R., Christner J.E., Ekborg S.L. Specificity of the low density lipoprotein-glycosaminoglycan interaction. Arterioscler Thromb. 11:1991;561-568.
37. Schmidt G., Hausser H., Kresse H. Interaction of the small proteoglycan decorin with fibronectin. involvement of the sequence NKISK of the core protein Biochem J. 280:1991;411-414.
38. Schwenke D.C., Carew T.E. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arterioscler. 9:1989;895-907.
39. Schwenke DC, Edwards IJ: 1996. Regional differences in aortic synthesis of sulfated proteoglycans correlate with susceptibility to atherosclerosis. (abst) Circulation 94:I-395.
40. Scott J.E. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. implications for their interactions with collagen Biochemistry. 35:1996;8795-8799.
41. Smith E.B. The influence of age and atherosclerosis on the chemistry of aortic intima. Part 2. Collagen and mucopolysaccharides J Atheroscler Res. 5:1965;241-248.
42. Smith E.B. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res. 12:1974;1-49.
43. Smith E.B. Transport, interactions and retention of plasma proteins in the intima. the barrier function of the internal elastic lamina Eur Heart J. 11(Suppl. E):1990;72-81.
44. Srinivasan S.R., Dolan B., Radhakrishnamurthy B., Pargaonkar P.S., Berenson G.S. Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesions. Biochim Biophys Acta. 388:1975;58-70.
45. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med. 320:1989;915-924.
46. Vijayagopal P., Srinivasan S.R., Radhakrishnamurthy B., Berenson G.S. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem. 256:1981;8234-8241.
47. Vijayagopal P., Figueroa J.E., Guo Q., Fontenot J.D., Tao Z. Marked alteration of proteoglycan metabolism in cholesterol-enriched human arterial smooth muscle cells. Biochem J. 315:1996;995-1000.
48. Völker W., Schmidt A., Buddecke E. Compartmentation and characterization of different proteoglycans in bovine arterial wall. J Histochem Cytochem. 34:1986;1293-1299.
49. Völker W., Schmidt A., Buddecke E. Mapping of proteoglycans in human arterial tissue. Eur J Cell Biol. 45:1987;72-79.
50. Wagner WD, Goldberg IJ, Parthasarathy N, Bottoms JD: 1997. Lipoprotein lipase enhances binding of decorin but not biglycan to low density lipoprotein. (abst) Circulation 96:I-39-I-40.
51. Walton K.W., Williamson N.J. Histological and immunofluorescent studies on the evolution of the human atheromatous plaque. J Atheroscler Res. 8:1968;599-624.
52. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem. 271:1996;31,767-31,770.
53. Wight T.N. Cell biology of arterial proteoglycans. Arteriosclerosis. 9:1989;1-20.
54. Williams K.J., Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol. 9:1998;471-474.
55. Winnemöller M., Schmidt G., Kresse H. Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol. 54:1991;10-17.
56. Winnemöller M., Schön P., Vischer P., Kresse H. Interactions between thrombospondin and the small proteoglycan decorin. interference with cell attachment Eur J Cell Biol. 59:1992;47-55.
57. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 346:1990;281-284.
58. Ylä-Herttuala S., Sumuvuori H., Karkola K., Möttönen M., Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest. 54:1986;402-407.